Table 2.

Association between traditional clinical variables and APM/T-cell factors

Clinical variablesPositive expression
TAP1TAP2TapasinHLA-HCβ2mIT CD3+/CD8+ T cellsPT CD3+/CD8+ T cells
AgeNSNS0.035NSNSNSNS
Low stage0.008NS0.001NSNSNS0.001
Low grade0.0110.0290.003NS0.035NSNS
Serous histologyNSNSNSNSNSNSNS
Preoperative CA125NSNSNSNSNSNS0.014
Ascites (−)NSNSNSNSNSNSNS
Optimal cytoreductionNSNSNSNSNSNSNS
Lymph nodes (−)0.0060.0210.045NSNSNS0.018
Distant metastasis (−)NSNSNSNS0.011NSNS
Positive expression
    TAP1**<0.001<0.001NS<0.001NS0.018
    TAP2<0.001**<0.001<0.001<0.0010.0030.001
    Tapasin<0.001<0.001**0.007<0.0010.007NS
    HLA-HCNS<0.0010.007**<0.0010.005<0.001
    β2m<0.001<0.001<0.001<0.001**0.0010.011
    IT CD3+/CD8+ T cellsNS0.0030.0070.0050.001**<0.001
    PT CD3+/CD8+ T cells0.0180.001NS<0.0010.011<0.001**
  • NOTE: χ2 Test was used for categorical data and the Wilcoxon rank sum test was used for continuous variables.

    Abbreviations: NS, not significant; β2m, β2 microglobulin; IT, intratumoral; PT, peritumoral; **, NA, not applicable.